MAEVE

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: 6137d228e5b6afd6
Drug Approval Canada Name: MAEVE
Product Name: MAEVE
Status: Marketed
Status Date: 2022-12-16
Original Market Date: 2022-12-16
Din: 02458683
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:12.00
Atc Original: G03AC01 NORETHISTERONE
Atc Name: g 03 ac 01
Aig Number: 0106372001
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

NORETHINDRONE

0.35 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6137d228e5b6afd6

Type

Standard